
Rafael Holdings, Inc. Class B Common Stock
RFL
RFL: Rafael Holdings Inc, through its subsidiaries, is a clinical stage, oncology-focused pharmaceutical company committed to the development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells.
moreShow RFL Financials
Recent trades of RFL by members of U.S. Congress
Recently reported changes by institutional investors
Quarterly net insider trading by RFL's directors and management
Government lobbying spending instances
New patents grants
Federal grants, loans, and purchases
Followers on RFL's company Twitter account
Number of mentions of RFL in WallStreetBets Daily Discussion
Recent insights relating to RFL
Recent picks made for RFL stock on CNBC
ETFs with the largest estimated holdings in RFL
Flights by private jets registered to RFL